Related Experiment Videos
Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunction
Volker Grünewald1, Klaus Höfner, Walter F. Thon
1Department of Urology, Hannover Medical School, Hannover, Germany.
Restorative Neurology and Neuroscience
|April 3, 2003
Summary
Chronic sacral neuromodulation offers sustained relief for urinary retention and motor urge incontinence. This effective treatment provides long-term benefits for patients refractory to conservative therapies.
Area of Science:
- Urology
- Neurology
- Biomedical Engineering
Background:
- Temporary electrical stimulation via anal/vaginal electrodes has treated urinary urge incontinence for decades.
- Chronic sacral nerve stimulation (SNS) was introduced in 1981 for refractory lower urinary tract dysfunction.
- SNS involves implanting a sacral foramen electrode and pulse generator for continuous nerve modulation.
Purpose of the Study:
- To evaluate the efficacy of chronic unilateral S3 sacral spinal nerve stimulation for vesicourethral dysfunction.
- To assess long-term symptomatic improvement in patients with urinary retention and motor urge incontinence.
- To compare the sustained therapeutic effects of chronic neuromodulation versus temporary techniques.
Main Methods:
- Chronic unilateral S3 sacral spinal nerve stimulation was applied to 43 patients.
- Patients had a mean postoperative follow-up of 43.6 months.
- Outcomes measured included symptomatic improvement in urinary retention and motor urge incontinence.
Main Results:
- Sustained symptomatic improvement (>50%) was achieved in 72.2% of motor urge incontinence patients (13/18).
- Sustained symptomatic improvement (>50%) was achieved in 85.7% of urinary retention patients (18/21).
- Chronic neuromodulation demonstrated a sustained therapeutic effect not seen with temporary methods.
Conclusions:
- Chronic sacral neuromodulation provides lasting symptom relief for specific urinary dysfunctions.
- It is particularly recommended for patients with urinary retention and those unresponsive to temporary neuromodulation.
- Despite initial costs, chronic SNS is economically viable long-term compared to alternative invasive treatments.